시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 스마트 약물전달 시스템(DDS) 시장 보고서(2024년)
Smart Drug Delivery Systems Global Market Report 2024
상품코드 : 1485211
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,000 ￦ 7,234,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,500 ￦ 10,851,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,000 ￦ 14,469,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

스마트 약물전달 시스템(DDS) 시장 규모는 향후 몇 년동안 빠르게 성장하여 2028년까지 연평균 19.7%의 연평균 복합 성장률(CAGR)로 259억 4,000만 달러 규모에 이를 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 비감염성 질환의 부담 증가, 정밀의료에 대한 관심 증가, 온도 측정의 부상, 비침습적 약물 전달 방법에 대한 수요 증가, 의료 지출의 지속적인 증가 등 여러 가지 요인에 기인합니다. 이 기간 동안 예상되는 주요 동향으로는 소형화 및 미세 가공 기술의 발전, 재료 과학의 혁신, 인공지능(AI)과 머신러닝(ML)의 통합, 나노 크기의 약물 전달 시스템 개발, IoT 및 웨어러블 기술의 약물 전달 시스템으로의 통합 등이 있습니다.

만성질환의 유병률 증가는 스마트 DDS(약물전달시스템) 시장의 성장을 견인할 것으로 보입니다. 만성질환은 진행이 느리고 원인이 복잡한 장기적인 건강 상태를 특징으로 하며, 고령화, 환경적 영향, 의료 접근성 격차 등의 요인으로 인해 증가 추세에 있습니다. 스마트 DDS(약물전달시스템)는 투약 효과를 높이고 환자의 순응도를 향상시켜 만성질환 관리에 유망한 솔루션을 제공합니다. 예를 들어, 미국 국립의학도서관(National Library of Medicine)의 자료에 따르면 2050년까지 최소 한 가지 이상의 만성질환을 앓고 있는 사람의 수가 크게 증가할 것으로 예상되며, 이는 만성질환 유병률 증가가 스마트 DDS(약물전달시스템) 시장 성장에 중요한 역할을 할 것으로 예상하고 있습니다. 만성질환 유병률 증가가 스마트 DDS(약물전달시스템) 시장을 견인하는 데 중요한 역할을 할 것으로 강조되고 있습니다.

스마트 약물전달 시스템(DDS) 시장의 주요 업체들은 약물 투여에 혁명을 가져올 혁신적인 재사용 가능한 약물 전달 기기 개발에 주력하고 있습니다. 그 중 하나는 Qfinity로, 약물의 피하 자가 투여를 위해 설계된 재사용 가능한 약물 전달 장치로, 1회용과 달리 여러 번 주사할 수 있어 폐기물을 줄이고 환경적 이점이 있습니다. 예를 들어, 자빌(Jabil Inc.)은 2022년 5월에 Qfinity를 출시했습니다. 이 장비는 1대당 100회 이상 주사할 수 있으며, 다양한 프리필드 카트리지를 사용할 수 있습니다. 이 장비는 주사 1회당 이산화탄소 배출량을 줄일 수 있을 뿐만 아니라, 다양한 약제량과 점도에 대응할 수 있는 다재다능함을 갖추고 있습니다. 또한, 커넥티드 버전의 Qfinity는 내장된 센서와 전자장치를 통해 환자 관리 및 컴플라이언스를 원격으로 모니터링할 수 있으며, 사용 편의성을 유지하면서 연결성을 보장합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

제5장 세계 시장 규모와 성장

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병(M&A)

제35장 향후 전망과 잠재적인 분석

제36장 부록

LSH
영문 목차

영문목차

Smart drug delivery systems encompass advanced technologies aimed at enhancing the efficacy, safety, and targeted delivery of pharmaceutical compounds within the body. These systems utilize diverse approaches to regulate drug release, improve bioavailability, and minimize adverse effects.

The primary products within smart drug delivery systems include connected inhalers, connected autoinjectors, connected pen injectors, connected wearable injectors, add-on sensors, and other related devices. Connected inhalers, for instance, are electronic monitoring systems integrated into inhalers, which track drug usage and may provide feedback on device technique. These systems find applications across various therapeutic areas such as metabolic disorders, neurological disorders, respiratory disorders, hormonal disorders, and more. They can deliver drugs via different modes including injectable, inhalation, and oral routes, and cater to a range of end users including hospitals, clinics, home care settings, ambulatory care facilities, among others.

The smart drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides smart drug delivery systems market statistics, including smart drug delivery systems industry global market size, regional shares, competitors with smart drug delivery systems market share, detailed smart drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the smart drug delivery systems industry. This smart drug delivery systems market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The smart drug delivery systems market size has grown rapidly in recent years. It will grow from $10.61 billion in 2023 to $12.65 billion in 2024 at a compound annual growth rate (CAGR) of 19.2%. The growth observed during the historic period can be attributed to several factors, including the increasing demand for drug delivery systems, rising patient compliance with treatment regimens, the growing prevalence of chronic diseases, the rise of personalized medicine approaches, and the need for cost-effective healthcare solutions.

The smart drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $25.94 billion in 2028 at a compound annual growth rate (CAGR) of 19.7%. The anticipated growth in the forecast period can be attributed to several factors, including the growing burden of non-communicable diseases, an increased focus on precision medicine, the rise of theragnostics, a growing demand for non-invasive drug delivery methods, and the continual increase in healthcare expenditure. Major trends expected during this period include advancements in miniaturization and microfabrication technologies, innovations in material science, the integration of artificial intelligence (AI) and machine learning (ML), the development of nano-sized drug delivery systems, and the integration of IoT and wearable technology into drug delivery systems.

The increasing prevalence of chronic diseases is poised to drive the growth of the smart drug delivery systems market. Chronic diseases, characterized by long-term health conditions with slow progression and complex causes, are on the rise due to factors such as aging populations, environmental influences, and disparities in healthcare access. Smart drug delivery systems offer a promising solution for managing chronic diseases by enhancing medication effectiveness and improving patient adherence. For example, data from the National Library of Medicine forecasts a substantial increase in the number of individuals with at least one chronic illness by 2050, underscoring the significant role of rising chronic disease prevalence in propelling the smart drug delivery systems market.

Key players in the smart drug delivery systems market are focused on developing innovative reusable drug delivery devices to revolutionize drug administration. One such device is Qfinity, a reusable drug delivery device designed for subcutaneous self-administration of medication. Unlike single-use devices, Qfinity can be utilized for multiple injections, reducing waste and offering environmental benefits. For instance, Jabil Inc. launched Qfinity in May 2022, featuring the capability to handle over 100 injections per device and accommodating various pre-filled cartridges. The device not only reduces the carbon footprint per injection but also offers versatility in handling different drug volumes and viscosities. Additionally, the connected version, Qfinity+, enables remote monitoring of patient care and compliance through built-in sensors and electronics, ensuring connectivity without compromising ease of use.

In October 2023, Novo Nordisk A/S strengthened its position in the smart drug delivery systems market through the acquisition of Biocorp Production SA for $164.5 million. This strategic move aims to augment Novo Nordisk's capabilities in developing innovative connected devices and delivery solutions, exemplified by Mallya, a smart add-on device for pen injectors. Biocorp, a France-based designer and manufacturer of medical devices and drug delivery systems, brings expertise in connected devices that align with Novo Nordisk's focus on advancing drug delivery technologies to enhance patient care and treatment outcomes.

Major companies operating in the smart drug delivery systems market are Pfizer Inc, Johnson & Johnson, Bayer AG, Abbott Laboratories, Novartis International AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Novo Nordisk, Merck Group, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc, Boston Scientific Corporation, Biogen Inc, Vertex Pharmaceuticals Incorporated, Phillips-Medisize Corporation, ResMed Inc., West Pharmaceutical Services Inc, Insulet Corporation, Owen Mumford Ltd, Sonceboz, H&T Presspart Manufacturing Ltd, E3D Elcam Drug Delivery Devices, CeQur Corporation

North America was the largest region in the smart drug delivery systems market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the smart drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smart drug delivery systems market consists of revenues earned by entities by providing services such as personalized drug delivery, targeted treatment, diagnostic integration, remote monitoring, and feedback mechanisms. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart drug delivery systems market also includes sales of products including microfluidic devices, transdermal drug delivery patches, electroceutical devices, and remote-controlled drug delivery devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Smart Drug Delivery Systems Market Characteristics

3. Smart Drug Delivery Systems Market Trends And Strategies

4. Smart Drug Delivery Systems Market - Macro Economic Scenario

5. Global Smart Drug Delivery Systems Market Size and Growth

6. Smart Drug Delivery Systems Market Segmentation

7. Smart Drug Delivery Systems Market Regional And Country Analysis

8. Asia-Pacific Smart Drug Delivery Systems Market

9. China Smart Drug Delivery Systems Market

10. India Smart Drug Delivery Systems Market

11. Japan Smart Drug Delivery Systems Market

12. Australia Smart Drug Delivery Systems Market

13. Indonesia Smart Drug Delivery Systems Market

14. South Korea Smart Drug Delivery Systems Market

15. Western Europe Smart Drug Delivery Systems Market

16. UK Smart Drug Delivery Systems Market

17. Germany Smart Drug Delivery Systems Market

18. France Smart Drug Delivery Systems Market

19. Italy Smart Drug Delivery Systems Market

20. Spain Smart Drug Delivery Systems Market

21. Eastern Europe Smart Drug Delivery Systems Market

22. Russia Smart Drug Delivery Systems Market

23. North America Smart Drug Delivery Systems Market

24. USA Smart Drug Delivery Systems Market

25. Canada Smart Drug Delivery Systems Market

26. South America Smart Drug Delivery Systems Market

27. Brazil Smart Drug Delivery Systems Market

28. Middle East Smart Drug Delivery Systems Market

29. Africa Smart Drug Delivery Systems Market

30. Smart Drug Delivery Systems Market Competitive Landscape And Company Profiles

31. Smart Drug Delivery Systems Market Other Major And Innovative Companies

32. Global Smart Drug Delivery Systems Market Competitive Benchmarking

33. Global Smart Drug Delivery Systems Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Smart Drug Delivery Systems Market

35. Smart Drug Delivery Systems Market Future Outlook and Potential Analysis

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기